Terbinafine HCl 250 mg Tablet Under Fasting Conditions

Clinical trial NCT00833586 · COMPLETED

Trial details

NCT number: NCT00833586
Sponsor: Teva Pharmaceuticals USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Start date: 2002-01-01
Primary completion: 2002-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.